The estimated Net Worth of Edward Wholihan is at least $1.45 millió dollars as of 17 December 2020. Mr. Wholihan owns over 164,822 units of Allena Pharmaceuticals Inc stock worth over $15,186 and over the last 7 years he sold ALNA stock worth over $0. In addition, he makes $1,437,540 as Chief Financial Officer at Allena Pharmaceuticals Inc.
Sign up
Mr. Wholihan ALNA stock SEC Form 4 insiders trading
Edward has made over 2 trades of the Allena Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 164,822 units of ALNA stock worth $13,186 on 17 December 2020.
The largest trade he's ever made was exercising 164,822 units of Allena Pharmaceuticals Inc stock on 17 December 2020 worth over $13,186. On average, Edward trades about 18,982 units every 95 days since 2018. As of 17 December 2020 he still owns at least 189,822 units of Allena Pharmaceuticals Inc stock.
You can see the complete history of Mr. Wholihan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Wholihan biography
Edward Wholihan is chief financial officer of the Company. Mr. Wholihan brings to us more than 25 years of financial, operational, and global business development leadership in the healthcare, life science, and technology sectors. From January 2015 to June 2016, Mr. Wholihan provided consulting and interim CFO and corporate development services to growth companies in the healthcare, life sciences, technology, and services industries. From June 2011 to July 2014, Mr. Wholihan served as Chief Financial Officer of Medical Specialties Distributors LLC, or MSD, a healthcare services provider. Prior to MSD, he served as Chief Financial Officer of Generation Health, Inc., a healthcare management company, from 2010 to 2011, and as Chief Financial Officer and Vice President of Business Development for Inovise Medical, Inc., a medical device company, from 2002 to 2009. Mr. Wholihan began his career at McKinsey & Company. Mr. Wholihan earned an M.B.A. from Stanford University’s Graduate School of Business and a B.A. in economics from Yale University.
What is the salary of Edward Wholihan?
As the Chief Financial Officer of Allena Pharmaceuticals Inc, the total compensation of Edward Wholihan at Allena Pharmaceuticals Inc is $1,437,540. There are 1 executives at Allena Pharmaceuticals Inc getting paid more, with Louis Brenner having the highest compensation of $2,980,630.
How old is Edward Wholihan?
Edward Wholihan is 60, he's been the Chief Financial Officer of Allena Pharmaceuticals Inc since 2016. There are 4 older and 10 younger executives at Allena Pharmaceuticals Inc. The oldest executive at Allena Pharmaceuticals Inc is Dr. Alexey L. Margolin, 68, who is the Co-Founder & Chairman.
What's Edward Wholihan's mailing address?
Edward's mailing address filed with the SEC is C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH, NJ, 07430.
Insiders trading at Allena Pharmaceuticals Inc
Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper és Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.
What does Allena Pharmaceuticals Inc's logo look like?
Complete history of Mr. Wholihan stock trades at Allena Pharmaceuticals Inc és KORU Medical Systems Inc
Allena Pharmaceuticals Inc executives and stock owners
Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Louis Brenner,
President, Chief Executive Officer, Director -
Edward Wholihan,
Chief Financial Officer -
Dr. Louis Brenner,
Pres, CEO & Director -
Dr. Alexey L. Margolin,
Co-Founder & Chairman -
Alexey Margolin,
Chairman of the Board, Co-Founder -
Geoffrey Swire,
Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development -
James Topper,
Independent Director -
Gino Santini,
Independent Director -
Andrew Hack,
Independent Director -
Allene Diaz,
Independent Director -
Robert Alexander,
Independent Director -
Ann Miller,
Director -
Stephen Yu,
Sr. VP of Corp. Quality -
Dr. David J. Clark,
Chief Medical Officer -
Alicja Januszewicz Ph.D.,
VP of People & Culture -
Hugh Wight,
Sr. VP of Technical Operations -
Dr. Richard D. Katz,
CFO, Principal Financial Officer & Principal Accounting Officer -
Robert Gallotto,
Co-Founder & Strategic Adviser -
Bio Capital Ii Lp Hbm,
10% owner -
Robert I Tepper,
Director -
Vi, L.L.C.Fhm Vi, L.P.Frazi...,
-
Harbor Master Investors (Ca...,
10% owner -
Venture Partners Vii L.P.De...,
-
Stephen Kraus,
Director -
Rock Ventures Ii, L.P.Third...,
-
Axel Bolte,
Director -
Richard D Katz,
Chief Financial Officer -
Mark J. Fitzpatrick,
Director